UCITS Funds
Advanced Medical Impact Equity Fund
Seeks to invest in innovative health care companies positioned for sustainably high growth. As the portfolio companies attain their fundamental growth objectives, they should also create a positive impact on society.
Concentrated Global Growth Equity Fund
Employs the same philosophy, process and team that we have used successfully in our Global Growth strategy since 1999. The concentrated portfolio represents our best ideas in the global market and seeks to provide a higher alpha alternative for global allocations.
Emerging Markets Equity Fund
Designed to generate alpha using a time-tested growth philosophy and process that helps us to identify companies early in their growth cycle. Our goal is to construct a portfolio of emerging market stocks that are experiencing accelerating growth that we believe to be sustainable over time.
Emerging Markets Sustainable Impact Equity Fund
Seeks to provide attractive risk-adjusted returns while achieving positive social and environmental impact by investing in companies experiencing accelerating growth that also contribute to one or more of the United Nations Sustainable Development Goals (SDGs).
Global Growth Equity Fund
Designed to generate alpha using a time-tested growth philosophy and process that helps us to identify companies early in their growth cycle. Our goal is to construct a portfolio of global stocks that are experiencing accelerating growth that we believe to be sustainable over time.
Global Small Cap Equity Fund
Designed to generate alpha using a time-tested growth philosophy and process that helps us to identify companies early in their growth cycle. Our goal is to construct a portfolio of companies with small market capitalizations that are located in both developed and emerging market countries.
US Focused Innovation Equity Fund
A large cap investment seeking innovative, rapid-growth companies within a high-conviction, risk-managed portfolio. The strategy typically holds 30-45 holdings stocks and focuses on generating long-term returns primarily through stock selection.
Availability, Literature and Daily NAV
American Century Investments sub-advises UCITS Funds (Nomura Funds Ireland, plc), advised by Nomura Asset Management U.K. Ltd. The sub-funds have been authorised for sale in:
Austria
Belgium
Canada
Denmark
Finland
France
Germany
Iceland
Ireland
Italy
Luxembourg
Netherlands
Norway
Portugal
Singapore
Spain
Sweden
Switzerland
United Kingdom
If you are a resident of one of these countries, access the Fund Documents page to view:
Daily NAV on the UCITS funds,
a listing of the funds available in your country and
multi-lingual versions (if available) of Fact Sheets, Key Investor Information Documents, Prospectus and other relevant documents.
Breakthrough Medical Research
Over 40% of Our Profits Contribute Every Year
Our corporate mission includes making an enduring, meaningful societal impact. Over 40% of our profits go to our controlling owner, the Stowers Institute for Medical Research, a world-class biomedical research organization dedicated to defeating life-threatening diseases.
The EU Sustainable Finance Disclosure Regulation (“SFDR”) requires investment firms to formalise how sustainability is integrated into their business and processes, and to make public and client-facing disclosures on sustainability matters. The aforementioned disclosures relating to Nomura Asset Management U.K. Limited are published on our website at https://www.nomura-asset.co.uk/responsible-investment-asset-management/esg-sustainable-investment/. Product related disclosures regarding Nomura Funds Ireland PLC and its sub-funds can be found in the prospectus. Nomura Funds Ireland – American Century Advanced Medical Impact Equity Fund is an Art. 9 fund according to SFDR. Nomura Funds Ireland – American Century Emerging Markets Sustainable Impact Equity Fund is an Art. 9 fund according to SFDR. Nomura Funds Ireland – American Century Concentrated Global Growth Equity Fund is an Art. 8 fund according to SFDR. Nomura Funds Ireland – American Century Emerging Markets Equity Fund is an Art. 8 fund according to SFDR. Nomura Funds Ireland – American Century Emerging Global Growth Equity Fund is an Art. 8 fund according to SFDR. Nomura Funds Ireland – American Century Emerging Global Small Cap Equity Fund is an Art. 8 fund according to SFDR. Nomura Funds Ireland – American Century US Focused Innovation Equity Fund is an Art. 6 fund according to SFDR.
The funds are sub-funds of Nomura Funds Ireland plc, which is authorised by the Central Bank of Ireland as an open-ended umbrella investment company with variable capital and segregated liability between its sub-funds, established as an undertaking for Collective Investment in Transferable Securities under the European Communities (Undertakings for Collective Investment in Transferable Securities) Regulations 2011. The UCITS funds are not intended for distribution to or use by any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation. Nomura Asset Management U.K. Ltd. is authorised and regulated by the Financial Conduct Authority.